Studies on Functional Regulation in Endogenous Regucalcin, An Intracellular Calcium Signaling Regulatory Protein, in Regucalcin Transgenic Rats

细胞内钙信号调节蛋白 Regcalcin 转基因大鼠内源性 Regcalcin 功能调节的研究

基本信息

  • 批准号:
    13672292
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

Regucalcin, which was discovered by Yamaguchi as a calcium-binding protein in 1978 years, has endogenous regucalcin was investigated by using regucalcin transgenic (RC-Tg) rats. The body weight of RC-Tg rats was significantly suppressed with increasing age. Endogenous regucalcin was markedly expressed in the organ tissues of the Tg rats. Especially, its expression was remarkable in the female rats rather than male rats, because the regucalcin gene is localized on chromosome X. The role of regucalcin in the regulation of cellular functions, which were found in normal rats, was also demonstrated in the organ tissues of RC-Tg rats. Bone loss was found to induce in the femoral tissues of RC-Tg rats with increasing age. This was based on stimulation of osteoclastic bone resorption. Regucalchin had a stimulatory effect on osteoclastic cell formation from bone marrow cells. Futhermore, hyperlipidemia was found to induce in RC-Tg rats with increasing. Also, a significant increase in serum albumin was induced in RC-Tg rats. RC-Tg rats were usfull as rat model for osteoporosis and hyperlipidemia with increasing age.
利用转Regucalin基因(RC-TG)大鼠研究了内源性Regucalin,它是山口在1978年发现的一种钙结合蛋白。RC-TG大鼠体重随增龄而明显抑制。内源性调节素在TG大鼠的脏器组织中有明显表达。特别是由于Regucalcin基因定位在X染色体上,所以在雌性大鼠中的表达显著高于雄性大鼠。在RC-TG大鼠的器官组织中也证实了Regucalcin在细胞功能调节中的作用,这在正常大鼠中也有发现。随着年龄的增长,RC-TG大鼠的股骨组织出现骨丢失。这是基于对破骨细胞性骨吸收的刺激。Regucalin对骨髓细胞形成破骨细胞有促进作用。此外,高脂血症对RC-TG大鼠有诱导作用,且呈递增趋势。同时,RC-TG大鼠血清白蛋白也显著升高。RC-TG大鼠作为增龄骨质疏松和高脂血症大鼠模型。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ma ZJ, Yamaguchi M: "Regulatory effect of regucalcin on nitric oxide synthase activity in rat kidney cortex cytosol : Role of..."International Journal of Molecular Medicine. 12. 201-206 (2003)
Ma ZJ,Yamaguchi M:“调节钙素对大鼠肾皮质细胞质中一氧化氮合酶活性的调节作用:......的作用”国际分子医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamaguchi M, Takahashi H, Tsurusaki Y: "Suppressive role of endogenous regucalcin in the enhancement of nitric oxide synthase activity in liver cytosol of normal and regucalcin transgenic rats."Journal of Cellular Biochemistry. 88. 1226-1234 (2003)
Yamaguchi M、Takahashi H、Tsurusaki Y:“内源性调节钙素在正常和调节钙素转基因大鼠肝细胞质中一氧化氮合酶活性增强中的抑制作用。”细胞生物化学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsurusaki Y, Yamaguchi M: "Role of endogenous regucalcin in transgenic rats : Suppression of protein tyrosine phosphatase and ribonucleic acid synthesis activities in liver nucleus."International Journal of Molecular Medicine. 12. 207-211 (2003)
Tsurusaki Y,Yamaguchi M:“内源性调节钙蛋白在转基因大鼠中的作用:抑制肝核中的蛋白酪氨酸磷酸酶和核糖核酸合成活性。”国际分子医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ichikawa E, Tsurusaki Y, Yamaguchi M: "Suppressive effect of regucalcin on protein phosphatase activity in the heart cytosol of normal and regucalcin transgenic rats."International Journal of Molecular Medicine. 13. 289-293 (2004)
Ichikawa E、Tsurusaki Y、Yamaguchi M:“调节钙素对正常和调节钙素转基因大鼠心脏细胞质中蛋白磷酸酶活性的抑制作用。”国际分子医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsurusaki Y., Yamaguchi, M: "Role of endogenous regucalcin in transgenic rats : Suppression of protein tyrosine phosphatase and..."International Journal of Molecular Medicine. 12. 207-211 (2003)
Tsurusaki Y.,Yamaguchi,M:“内源性调节钙蛋白在转基因大鼠中的作用:蛋白酪氨酸磷酸酶的抑制和......”国际分子医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAGUCHI Masayoshi其他文献

YAMAGUCHI Masayoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAGUCHI Masayoshi', 18)}}的其他基金

Transcriptional Regulatory Mechanism for Ca^<2+>-Signaling Regulatory Protein Regucalcin Gene Which Is Expressed Specifically in Liver Cells
肝细胞特异表达的Ca^2信号调节蛋白Reguccalcin基因的转录调控机制
  • 批准号:
    10672048
  • 财政年份:
    1998
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene Expression of Regulatory Protein Regucalcin of Ca^<2+>-Signaling and Its Regulatory Mechanism.
Ca^2-信号调节蛋白Reguccalcin的基因表达及其调节机制。
  • 批准号:
    08672522
  • 财政年份:
    1996
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Expression of a novel Ca^<2+>-binding protein regucalcin and rlation to its physiologic role
新型Ca^2结合蛋白regcalcin的表达及其生理作用的关系
  • 批准号:
    06672193
  • 财政年份:
    1994
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Regulatory role of ca^<2+> -binging protein requcalcin in signal transduction system and its mechanism
ca^2结合蛋白requcalcin对信号转导系统的调节作用及其机制
  • 批准号:
    04671362
  • 财政年份:
    1992
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Studies on Liver Cellular Functions by a Novel Ca^<2+>-Binding Protein Regucalcin
新型Ca^<2>-结合蛋白Reguccalcin对肝细胞功能的研究
  • 批准号:
    02671006
  • 财政年份:
    1990
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Studies on the Role of A Novel Ca^<2+>-Binding Protein Regucalcin in Liver Cell Functions
新型Ca^2结合蛋白Reguccalcin对肝细胞功能作用的研究
  • 批准号:
    63571053
  • 财政年份:
    1988
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Pathological analysis using transgenic rats that produce acute retinitis pigmentosa.
使用产生急性色素性视网膜炎的转基因大鼠进行病理分析。
  • 批准号:
    23K09034
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
STUDY ON NEURODEGENERATION USING TDP-43 TRANSGENIC RATS
TDP-43 转基因大鼠神经退行性研究
  • 批准号:
    10198111
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Establishment of S100A9 transgenic rats to understand S100 proteins' immunological role
建立S100A9转基因大鼠以了解S100蛋白的免疫学作用
  • 批准号:
    17K15786
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Visualization and quantification of the oxytocinergic pain and inflammation-related descending inhibitory pathways using transgenic rats
使用转基因大鼠对催产素疼痛和炎症相关的下行抑制途径进行可视化和量化
  • 批准号:
    17K11039
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypothalamo-neurohypophysial and hypothalamo-spinal nociceptive pathways in the arthritis using transgenic rats
使用转基因大鼠研究关节炎中的下丘脑-神经垂体和下丘脑-脊髓伤害感受通路
  • 批准号:
    16K10925
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The analysis of extracellular vesicles in fetal and neonatal period using transgenic rats
转基因大鼠胎儿期和新生儿期细胞外囊泡的分析
  • 批准号:
    16K14601
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Study on Neurodegeneration using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经变性研究
  • 批准号:
    9026917
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
Study on Neurodegeneration using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经变性研究
  • 批准号:
    9195755
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
Elucidation of nociceptive pathways using c-fos eGFP transgenic rats
使用 c-fos eGFP 转基因大鼠阐明伤害感受途径
  • 批准号:
    26860164
  • 财政年份:
    2014
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
HAART-mediated Cardiovascular Toxcity in HIV-1 Transgenic Rats: Mg Protection
HIV-1 转基因大鼠中 HAART 介导的心血管毒性:镁保护
  • 批准号:
    8906935
  • 财政年份:
    2014
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了